Skip to main content
. 2024 May 7;99(Suppl 2):S249–S263. doi: 10.3233/JAD-221241

Table 2.

AD pathway genes identified to be significantly correlated with FAM222A expression levels in ACT study

TCx FWM HIP PCx
Gene Correlation Coefficient p Correlation Coefficient p Correlation Coefficient p Correlation Coefficient p
ABCG1 0.49 2.93E-07 0.61 5.96E-11 0.49 4.09E-07 0.53 5.22E-08
APOE –0.09 4.00E-01 0.41 3.64E-05 0.21 4.12E-02 0.18 9.36E-02
ATP2A3 –0.06 5.83E-01 0.25 1.54E-03 0.24 2.19E-03 –0.11 2.89E-01
AXIN1 0.36 2.70E-04 0.54 2.07E-08 0.37 2.69E-04 0.40 1.01E-04
BACE1 0.50 1.11E-07 0.73 8.67E-17 0.33 1.16E-03 0.63 3.03E-11
BCL11A –0.19 6.07E-02 –0.79 2.05E-21 –0.07 5.24E-01 –0.20 5.26E-02
CALM2 –0.31 1.93E-03 –0.13 2.12E-01 –0.27 7.33E-03 –0.15 1.59E-01
CAPN2 0.15 1.34E-01 0.47 2.54E-06 0.12 2.42E-01 0.07 5.26E-01
CLU –0.05 6.12E-01 –0.42 3.51E-05 0.02 8.66E-01 –0.01 9.59E-01
GRIN2B –0.47 1.07E-06 –0.83 7.28E-25 –0.39 1.22E-04 –0.50 3.59E-07
IRS1 0.13 1.93E-01 –0.68 4.42E-14 –0.24 1.77E-02 –0.10 3.42E-01
KIF5A 0.09 3.86E-01 –0.69 1.43E-14 0.07 5.21E-01 –0.11 2.90E-01
KIF5B –0.50 1.06E-07 –0.56 5.97E-09 –0.40 5.82E-05 –0.36 4.95E-04
KIF5C –0.16 1.08E-01 –0.38 1.48E-04 –0.21 4.36E-02 –0.25 1.59E-02
LDLRAP1 0.66 1.40E-13 0.73 1.61E-16 0.67 1.36E-13 0.75 1.53E-17
MTOR –0.19 5.68E-02 –0.46 3.17E-06 –0.16 1.23E-01 –0.07 4.90E-01
NEFH –0.06 5.51E-01 –0.63 9.10E-12 –0.10 3.46E-01 –0.10 3.66E-01
NEFM –0.17 9.95E-02 –0.74 4.81E-17 –0.05 6.34E-01 –0.17 1.05E-01
PSEN1 0.61 1.34E-11 0.81 1.43E-22 0.49 6.52E-07 0.64 8.43E-12
PSEN2 –0.24 1.78E-02 –0.68 5.16E-14 –0.26 1.01E-02 –0.06 5.57E-01
PSMD12 –0.35 4.66E-04 –0.66 4.21E-13 –0.41 3.44E-05 –0.39 1.08E-04
TUBA1A 0.07 4.63E-01 0.57 2.10E-09 0.01 9.29E-01 0.29 5.54E-03
VPS35 –0.36 2.20E-04 –0.71 9.16E-16 –0.45 4.19E-06 –0.39 1.40E-04
WNT16 0.17 9.94E-02 0.61 7.55E-11 0.02 8.32E-01 0.24 2.14E-02
ZDHHC1 0.09 3.95E-01 0.45 7.81E-06 0.01 9.08E-01 0.10 3.22E-01

TCx, temporal neocortex; FWM, white matter of forebrain; HIP, hippocampus; PCx, parietal neocortex.